According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...
PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, has reported the ...
PulseSight Therapeutics has unveiled positive phase 1 results for PST‑611, its non‑viral gene therapy candidate for dry ...
About Dr. James Leong: Dr. James Leong is an Oxford fellowship-trained consultant ophthalmologist specializing in medical retina, uveitis, and refractive cataract surgery. He is the founder of The Eye ...
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of $130.0 million aggregate principal ...
But when the retina is damaged, vision can slowly become blurred, distorted or permanently lost, often before a person even ...
Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...
Growing at a rapid pace, Apex Eyecare is poised to hire a second optometrist and a nurse practitioner in the coming months, ...
On March 24, 2026, Ocugen reported positive 12‑month topline data from its Phase 2 ArMaDa trial of OCU410, a one-time AAV5-based modifier gene therapy for geographic atrophy secondary to dry ...
With Bahrain entering the peak summer period, attention must be paid to the different ways prolonged sun exposure can affect ...
Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...
Quitting smoking and getting regular eye exams may lower your risk of macular degeneration. Eating a Mediterranean diet can reduce your risk of advanced AMD by 41%. You can wear sunglasses that block ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results